Physician
Internal Medicine
Dr. Thomas A. Bayer, MD
|
|
Give Review
Thomas A. Bayer, MD works in the field of Internal Medicine. He graduated from University of Illinois College of Medicine at Chicago. University of Illinois College of Medicine at Chicago is ranked 49 in research and 85 in primary care medicine Doctor Thomas A. Bayer, MD is a published physician. He has 52 publications published. The most current publication "Antibody 9D5 Recognizes Oligomeric Pyroglutamate Amyloid-? in a Fraction of Amyloid-? Deposits in Alzheimer's Disease without Cross-Reactivity with other Protein Aggre..." He accepts Medicare.
Publications
- Antibody 9D5 Recognizes Oligomeric Pyroglutamate Amyloid-? in a Fraction of Amyloid-? Deposits in Alzheimer's Disease without Cross-Reactivity with other Protein Aggre...
- A?PP Accumulation and/or Intraneuronal Amyloid-? Accumulation? The 3xTg-AD Mouse Model Revisited.
- Pyroglutamate Abeta -- a hatchet man in Alzheimer disease.
- No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease.
- Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues...
- Disturbed copper bioavailability in Alzheimer's disease.
- Identification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosis.
- Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease.
- Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.
- Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.
- Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein.
- Environmental enrichment fails to rescue working memory deficits, neuron loss, and neurogenesis in APP/PS1KI mice.
- Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Abeta in plasma of patients with Alzheimer's disease.
- Cellular copper import by nanocarrier systems, intracellular availability, and effects on amyloid beta peptide secretion.
- Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease.
- Sortilin-related receptor with A-type repeats (SORLA) affects the amyloid precursor protein-dependent stimulation of ERK signaling and adult neurogenesis.
- Age-dependent axonal degeneration in an Alzheimer mouse model.
- Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels.
- Intraneuronal beta-amyloid is a major risk factor--novel evidence from the APP/PS1KI mouse model.
- Altered cholesterol metabolism in APP695-transfected neuroblastoma cells.
- New insights into Alzheimer''s disease: ''modeling neurodegeneration - causes and consequences''.
- High spatial resolution contrast-enhanced MR angiography of the supraaortic arteries using the quadrature body coil at 3.0T: a feasibility study.
- Tactile acuity in experienced Tai Chi practitioners: evidence for use dependent plasticity as an effect of sensory-attentional training.
- Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: ex-vivo and in-vivo inve...
- Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement.
- Stress fracture of the hook of the hamate as a result of intensive climbing.
- Ultrasound monitoring of kidney stone extracorporeal shockwave lithotripsy with an external transducer: does fatty tissue cause image distortions that affect stone com...
- A simple route to univalent gallium salts of weakly coordinating anions.
- Laser treatment of benign prostatic obstruction: basics and physical differences.
- Motor impairment in Alzheimer''s disease and transgenic Alzheimer''s disease mouse models.
- Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment.
- Gender dependent APP processing in a transgenic mouse model of Alzheimer''s disease.
- [Alzheimer''s disease. Molecular pathology, animal models, and current treatment].
- The influence of concentric and eccentric loading on the finger pulley system.
- [Splints in birth-related brachial plexus injuries].
- [Atraumatic osteodural defect of the skull base as etiology of intermittent cerebrospinal fluid rhinorrhea: MRI and CT diagnosis].
- Robust photon locking.
- Formic acid is essential for immunohistochemical detection of aggregated intraneuronal Abeta peptides in mouse models of Alzheimer''s disease.
- Intraneuronal Aβ as a trigger for neuron loss: can this be translated into human pathology?
- Neuron loss in transgenic mouse models of Alzheimer''s disease.
- Intracellular accumulation of amyloid-Beta - a predictor for synaptic dysfunction and neuron loss in Alzheimer''s disease.
- Accumulation of intraneuronal Abeta correlates with ApoE4 genotype.
- Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer''s disease, se...
- Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer''s disease cases.
- Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model.
- APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.
- Circulating immune complexes of Abeta and IgM in plasma of patients with Alzheimer''s disease.
- Effect of copper intake on CSF parameters in patients with mild Alzheimer''s disease: a pilot phase 2 clinical trial.
- Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.
- Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice.
- Intake of copper has no effect on cognition in patients with mild Alzheimer''s disease: a pilot phase 2 clinical trial.
Schools
Suny Downstate Medical Center
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
University of Illinois College of Medicine at Chicago -
State University of New York Downstate Medical Center College of Medicine
Drug Facts
| NPI NUMBER | 1710276316 | |
| NPPES Provider LastName | BAYER | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 631418232 | |
| NPPES Provider State | MO | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 575.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 2.09 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710276316 |
| Last Name Of The Provider | BAYER |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
|
Dr. Robbie T. Mangalasseril, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maya T. Khoukaz, MD |
|
|
Dr. Kyla A. Dewar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy J. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irwin Schultz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dusty Kime, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy B. Lumpkin, MD |
|
Dr. Kathleen M. Garcia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter I. Angelin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura J. Kroupa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anuradha R. Kotha, MD |
|
|
Dr. Garrett A. Hagen Jr., MD
This Doctor is OpenDoctor Recommended.
|